TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/21/21 17:28 | 10/19/21 | MGTX | Meiragtx Holdings Plc | E9 | Health | BioPrd | Biological Products, (No Diag | Giroux Richard | NY | O | CFO,COO | S.m | -462 | 20.99 | 0 | -22 | -2 | 909 | D | ||||||||||||||
12/21/20 17:08 | 12/17/20 | MGTX | Meiragtx Holdings Plc | E9 | Health | BioPrd | Biological Products, (No Diag | Giroux Richard | NY | O | CFO,COO | S | -288 | 16.00 | 0 | -18 | -2 | 937 | D | ||||||||||||||
5/22/20 17:44 | 5/20/20 | MGTX | Meiragtx Holdings Plc | E9 | Health | BioPrd | Biological Products, (No Diag | Giroux Richard | NY | O | CFO,COO | S.m | -271 | 15.12 | 0 | -18 | -2 | 1,155 | D | ||||||||||||||
5/15/20 17:10 | 5/13/20 | MGTX | Meiragtx Holdings Plc | E9 | Health | BioPrd | Biological Products, (No Diag | Giroux Richard | NY | O | CFO,COO | S | -1 | 15.38 | 0 | 0 | 0 | 1,173 | D | ||||||||||||||
1/23/20 16:42 | 1/21/20 | MGTX | Meiragtx Holdings Plc | E9 | Health | BioPrd | Biological Products, (No Diag | Giroux Richard | NY | O | CFO,COO | S.m | -350 | 19.45 | 0 | -18 | -2 | 1,173 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |